Wall Street Braces for Emerging-Market Jolt by Dodging Dollar

Wall Street Braces for Emerging-Market Jolt by Dodging Dollar

LAGOS (Capital Markets in Africa) – After two years of almost uninterrupted gains in developing-nation currencies against the U.S. dollar, it’s time for a new strategy. That’s the assessment of traders who’ve grown anxious that the greenback’s 16 percent slide against a basket of emerging-market currencies since January 2016 has gone too far. The latest inflation reading in the world’s largest economy added to concern, possibly giving the Federal Reserve cover to tighten monetary policy. At the same time,…

Read More

Swiss Regulator Shuts Down `Fake Cryptocurrency’ Firm E-Coin

Swiss Regulator Shuts Down `Fake Cryptocurrency’ Firm E-Coin

LAGOS (Capital Markets in Africa) – Financial Market Supervisory Authority closed unauthorized providers of “fake cryptocurrency” E-Coin after the company accepted millions of francs in public deposits without holding a banking license, Finma says in statement. Finma started bankruptcy proceedings against legal entities involved Quid Pro Quo has been issuing E-Coins and ran an online trading platform together with Digital Trading AG and Marcelco Group AG The three entities accepted funds amounting to at least…

Read More

Vodafone Mobile Operations Halted in Cameroon Over License Issue

Vodafone Mobile Operations Halted in Cameroon Over License Issue

YAOUNDE (Capital Markets in Africa) – Vodafone Group Plc’s operations in Cameroon have been halted after the country’s telecommunications regulator ruled that a license had been incorrectly awarded to the local partner of the U.K. wireless carrier. The west African nation’s Telecommunications Regulatory Board allowed Vodafone Cameroon to provide internet and mobile services in the country without government approval, Posts and Telecommunications Minister Minette Libom Li Likeng said in interview in the capital, Yaounde, on…

Read More

UBS Wealth Has Good Things to Say About EM, Not South Africa

UBS Wealth Has Good Things to Say About EM, Not South Africa

JOHANNESBURG (Capital Markets in Africa) – There’s one emerging market country that Michael Bolliger can’t get bullish about at the moment: South Africa. President Jacob Zuma is fighting to stay out of court before the African National Congress votes for a new leader in December. He’s pushing for his ex-wife to succeed him, but most analysts in a Bloomberg survey think the nation’s Deputy President Cyril Ramaphosa probably will. It’s more noise for a market that has already paid a price…

Read More

Bitcoin’s Biggest Challenge? Too Many Americans Think It’s Illegal to Own

Bitcoin’s Biggest Challenge? Too Many Americans Think It’s Illegal to Own

LAGOS (Capital Markets in Africa) – About 11% of respondents in a recent survey said owning bitcoin was breaking the law and close to half weren’t sure if it’s legal or not. Although 78.6% of Americans have heard of bitcoin, close to 11% think the cryptocurrency is illegal and 48% aren’t sure of its legality, according to new data from a LendEDU survey of 1,000 people. Bitcoin is, in fact, completely legal to own. But…

Read More

Dangote Cement Approaches South Africa’s PPC About Takeover

Dangote Cement Approaches South Africa’s PPC About Takeover

LAGOS (Capital Markets in Africa) – Dangote Cement Plc has approached PPC Ltd. about a takeover deal, signalling the start of a possible bidding war for South Africa’s biggest cement maker after an earlier offer led by Canada’s Fairfax Financial Holdings Ltd. Dangote has told PPC’s board that it’s interested in buying “the entire share capital,” the Lagos-based company said late Wednesday in a statement to the Nigerian Stock Exchange. “This communication is still at the preliminary…

Read More

Aspen Buys Remaining Rights to AstraZeneca’s Anesthetics

Aspen Buys Remaining Rights to AstraZeneca’s Anesthetics

LAGOS (Capital Markets in Africa) – Aspen Pharmacare Holdings Ltd. is resuming deal making, agreeing to buy more rights to AstraZeneca Plc’s anesthetic medicines for $555 million while reporting full-year profit that beat analysts’ estimates.  Earnings per share at Africa’s largest generic-drugs maker climbed 16 percent to 14.63 rand in the year through June, the Durban, South Africa-based company said in a statement on Thursday. Analysts expected 14.61 rand. Sales also increased 16 percent to 41.2 billion rand ($3.1…

Read More
1 168 169 170 171 172 255